FLT3 and acute myeloid leukemia: For EFS the following variables were included to the model: extramedullary AML, HMA pretreatment, mutated PTPN11, FLT3, NF1, and SF3B1. Based on the individual scores patients were stratified into three risk groups for EFS analogous to OS (Supplementary Fig. S6B).